Market Place
Sourcing Support
Annovis Releases Alzheimer`s Phase 2/3 Trial Results In Nature
28 Apr 2026 //
GLOBENEWSWIRE
Annovis Raises $10M for Ph 3 Alzheimer Disease`s NDA Submission
10 Apr 2026 //
GLOBENEWSWIRE
Annovis Launches $10M Common Stock Offering With Warrants
09 Apr 2026 //
GLOBENEWSWIRE
Annovis Patents Buntanetap for Neurological Infection Injuries
02 Apr 2026 //
GLOBENEWSWIRE
Annovis Publishes Historical Review in The Scientist
31 Mar 2026 //
GLOBENEWSWIRE
Annovis Reports Fiscal Year 2025 Financial Results
16 Mar 2026 //
GLOBENEWSWIRE
Annovis Announces Two Presentations at the AD/PD 2026 Conference
03 Mar 2026 //
GLOBENEWSWIRE
Annovis Advances Buntanetap Phase 3 Trial In Alzheimer Disease
12 Feb 2026 //
GLOBENEWSWIRE
Annovis To Host Corporate Update Webinar On January 28, 2026
16 Dec 2025 //
GLOBENEWSWIRE
Annovis To Present At 2025 Parkinson Study Group Meeting
03 Dec 2025 //
GLOBENEWSWIRE
Annovis Announces Two Presentations At CTAD 2025 Conference
24 Nov 2025 //
GLOBENEWSWIRE
Annovis Announces Meeting to Discuss Parkinson`s Dementia Program
18 Nov 2025 //
GLOBENEWSWIRE
Annovis Links Amyloid Co-Pathology To Cognitive Decline in PD
17 Nov 2025 //
GLOBENEWSWIRE
Annovis Hits Key Milestones in Phase 3 Alzheimer`s Trial
06 Nov 2025 //
GLOBENEWSWIRE
Annovis Announces $6 M Registered Direct Offering of Common Stock
10 Oct 2025 //
GLOBENEWSWIRE
Annovis Reports Biomarker Data Backing Buntanetap in Alzheimer
09 Oct 2025 //
GLOBENEWSWIRE
Annovis Appoints Mark Guerin as Chief Financial Officer
25 Sep 2025 //
GLOBENEWSWIRE
Annovis Highlights Pharmacokinetics of Novel Crystal Buntanetap
16 Sep 2025 //
GLOBENEWSWIRE
Annovis to Present at H.C. Wainwright Investment Conference
02 Sep 2025 //
GLOBENEWSWIRE
Annovis Completes Full Patent Transfer to Crystal Buntanetap
07 Aug 2025 //
GLOBENEWSWIRE
Annovis to Attend the AAIC 2025 with Four Poster Presentations
26 Jun 2025 //
GLOBENEWSWIRE
Annovis` Plan Accepted by NYSE for Listing Compliance
19 Jun 2025 //
GLOBENEWSWIRE
Annovis Bio Appoints Hui Liu as Director of Biostatistics
29 Apr 2025 //
GLOBENEWSWIRE
Annovis Bio Receives Continue Listing Standard Notice From the NYSE
27 Mar 2025 //
GLOBENEWSWIRE
Annovis to Attend AD/PD 2025 with Scientific Program
25 Mar 2025 //
GLOBENEWSWIRE
Innovative Drug Combinations Offer New Hope for Alzheimer`s and More
03 Oct 2024 //
PR NEWSWIRE
Annovis Bio To Present At H.C. Wainwright Conference
05 Sep 2024 //
GLOBENEWSWIRE
Annovis Announces Publication That Supports Buntanetap`s MOA in Humans
01 Apr 2024 //
GLOBENEWSWIRE
Annovis blames ‘data cleaning’ for ph. 3 Parkinson’s data delays
24 Jan 2024 //
FIERCE BIOTECH
Annovis Bio Measures Novel Biomarkers in Plasma of Parkinson’s Patients
02 Nov 2023 //
BUSINESSWIRE
